Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial — Meletios A Dimopoulos (2016) | RDL Network
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Meletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, Jeffrey Matous, David MacDonald, Constantine S. Tam, O. Tournilhac, Shuo Ma, Albert Oriol, Leonard T. Heffner, Chaim Shustik, Ramón García‐Sánz, Robert F. Cornell, Carlos Fernández de Larrea, Jorge J. Castillo, Miquel Granell, Marie‐Christine Kyrtsonis, Véronique Leblond, Argiris Symeonidis, Priyanka Singh, Jianling Li, Thorsten Graef, Elizabeth Bilotti, Steven P. Treon, Christian Buske
Judith Trotman, Christian Buske, Alessandra Tedeschi, Jeffrey Matous, D. Blair Macdonald, Constantine S. Tam, Olivier Tournilhac, Shuo Ma, Steven P. Treon, Albert Oriol, Jerry Ping, Eva M. Briso, Israel Arango‐Hisijara, Meletios A Dimopoulos
M. Lia Palomba, Meletios A Dimopoulos, Alessandra Tedeschi, Judith Trotman, Ramón García‐Sánz, David MacDonald, Véronique Leblond, Beatrice Mahé, Charles Herbaux, Constantine S. Tam, Jeffrey Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, Jianling Li, Zeena Salman, Thorsten Graef, Christian Buske
Judith Trotman, Christian Buske, Alessandra Tedeschi, Jeffrey Matous, D. Blair Macdonald, Constantine S. Tam, Olivier Tournilhac, Shuo Ma, Steven P. Treon, Albert Oriol, Jerry Ping, Eva M. Briso, Israel Arango‐Hisijara, Meletios A Dimopoulos
Meletios A Dimopoulos, Alessandra Tedeschi, Judith Trotman, Ramón García‐Sánz, D. Blair Macdonald, Véronique Leblond, Beatrice Mahé, Charles Herbaux, Constantine S. Tam, Lorella Orsucci, M. Lia Palomba, Jeffrey Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, Jianling Li, Zeena Salman, Thorsten Graef, Christian Buske
Discussion(0)
No comments yet. Be the first to comment.